Condition: Serum Uric Acid · Sponsor: Hepatopancreatobiliary Surgery Institute of Gansu Province
This retrospective study aims to analyze the impact of postoperative changes in serum uric acid (SUA) levels on the prognosis of patients undergoing pancreatic cancer resection.
This description comes directly from the study's public registry record.
Wenbo Meng, M.D. Ph. D. · 13919177177 · mengwb@163.com
Zhengping An, M.D. · 18298415512 · anzhp2023@lzu.edu.cn
Always discuss trial participation with your own doctor first.
| Hepatopancreatobiliary Surgery Institute of Gansu Province | Lanzhou, Gansu, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07091526